发明授权
- 专利标题： Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor
-
申请号： US12816995申请日： 2010-06-16
-
公开(公告)号： US08343989B2公开(公告)日： 2013-01-01
- 发明人: James P. Edwards , David E. Kindrachuk , Christopher M. Mapes , Daniel J. Pippel , Jennifer D. Venable
- 申请人： James P. Edwards , David E. Kindrachuk , Christopher M. Mapes , Daniel J. Pippel , Jennifer D. Venable
- 申请人地址： BE Beerse
- 专利权人： Janssen Pharmaceutica NV
- 当前专利权人： Janssen Pharmaceutica NV
- 当前专利权人地址： BE Beerse
- 主分类号： C07D401/14
- IPC分类号： C07D401/14 ; A61K31/4184
摘要：
Benzoimidazol-2-yl pyrimidines and pyrazines, pharmaceutical compositions and methods for H4 receptor activity modulation and for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritis.
公开/授权文献
信息查询
